McClellan CMS (Centers for Medicare & Medicaid Services) vote ahead
This article was originally published in Clinica
Executive Summary
The Senate Finance Committee has scheduled a March 8 confirmation hearing and a March 9 vote on the nomination of FDA Commissioner Mark McClellan to lead the Centers for Medicare & Medicaid Services (CMS). The panel agreed to the hurry-up schedule in hopes that the full Senate could act on Dr McClellan's nomination by the week's end before lawmakers go home for a week-long recess.